Participant’s takeaways from 2019 Medical Device Playbook Medical Device Playbook was conceived as a way to inspire entrepreneurship and connect the many players in the Medical Device world. In seven words, I would describe this as an “informative and inspirational storytelling event, great people”. Medtech innovators and investors described their first-hand commercialization, partnership, regulatory, and […]
Posts categorized as“Biotech”
50 years of research in stem cell biology, immunology, molecular biology, genomics, engineering and advanced materials, are transforming the therapeutic landscape much like antibiotics once did for infectious diseases. Regenerative Medicine (RM) and advanced therapeutic products encompass a very diverse and broad range of approaches that enable the body to repair, replace, restore and regenerate […]
I suggest that Regenerative Medicine will be associated with a parallel revolution in medicine- much like introduction of the world wide web and the internet in the ’90s caused a revolution in global communications and information technologies. As with all revolutions, history records that there are those that can thrive, adapt and ride the tides […]
Dr. Stephanie Willerth is the Acting Director of the Biomedical Engineering program and the Centre for Biomedical Research at the University of Victoria, and Member of the International Collaboration on Repair Discoveries (ICORD). We spoke recently about her current research in Regenerative Medicine and collaborations with StarFish Medical.
Chimeric antigen receptor T-cell (CAR-T) therapy is a rising shining star in Regenerative Medicine. Medical devices will be involved in many of the processes involved with CAR-T therapies. From blood collection, to T-cell isolation and activation, modification, expansion and product formulation, preconditioning and finally T-Cell infusion and delivery, there will be an evolution in the […]
Cellular reprogramming is a promising new strategy for a variety of medical applications. One of many new and intriguing areas of biomedical engineering research, cellular reprogramming is a process where an adult cell is flipped from one type directly into another.
When selecting a method for developing an assay, whether it is for detecting bacteria or simulating fluid, the approach all depends on the application and your target market. For example, Escherichia coli (or E. coli as it is more commonly known) can be found everywhere, from lettuce sold at a supermarket to your kids’ diaper. […]
5 tips to a successful academic-industrial partnership Costs are rising for research so how do you maximize your biotech R&D budget? Form an academic-industrial partnership. Perhaps you are working on a disruptive technology and need an expert to assess that your assay is better than the accepted standard? Or maybe you’ve had a pet research […]
Medical devices such as glucose meters, stents or dialysis equipment (to name a few) require intimate contact with biological material. They must either interact with bodily fluids, or function within a biological environment. This blog provides 5 of the most common simulated biological fluid recipes to aide in medical device development.
For insight into Infectious diseases Point of Care (POC) assay industry trends I’ve summarized several leading sources for trends including the World Health Organization, the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting key topics, and an Ipsos Mori poll published by the Bill and Melinda Gates Foundation.